Arata Azuma

Jumonji University — Japan

Medicine · Health Sciences

65h-index26.2kcitations521works5.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis(270), Sarcoidosis and Beryllium Toxicity Research(61), Chronic Obstructive Pulmonary Disease (COPD) Research(40), Systemic Sclerosis and Related Diseases(38), Eosinophilic Disorders and Syndromes(31)

Publications521 total

Design of an open-label extension trial of nerandomilast (BI 1015550) in patients with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis (FIBRONEER™-ON)
BMC Pulmonary Medicine·2025Open Access
Late Breaking Abstract - Effect of nerandomilast on clinical outcomes in patients with progressive pulmonary fibrosis (PPF): results from the final database lock of the FIBRONEER-ILD trial
2025
Initiation of supplemental oxygen in the FIBRONEER-IPF trial of nerandomilast in patients with idiopathic pulmonary fibrosis
2025
Late Breaking Abstract - A multi-ancestry meta-analysis offers new insights into the genetics of sarcoidosis, leveraging data from over 2 million individuals across global biobanks and the MESARGEN Consortium
2025
Effect of nerandomilast in subgroups of patients with idiopathic pulmonary fibrosis (IPF) in the FIBRONEER-IPF trial
2025
Late Breaking Abstract - Effect of nerandomilast on clinical outcomes in patients with idiopathic pulmonary fibrosis (IPF): data from final database lock of the FIBRONEER-IPF trial
2025
Late Breaking Abstract - Safety and tolerability of nerandomilast in patients with pulmonary fibrosis: pooled data from the FIBRONEER-IPF and FIBRONEER-ILD trials
2025
Pulmonary sarcoidosis clinical trial end-points: a Delphi study
European Respiratory Journal·2025· 2 cited
The Influence of Interpersonal Communication, Professionalism and Competence on The Monitoring System and Hospital Paramedic Performance at Dr. H. Soewondo Kendal Regional Hospital
Professional Evidence-based Research and Advances in Wellness and Treatment·2025Open Access
Nerandomilast in Patients with Progressive Pulmonary Fibrosis
New England Journal of Medicine·2025· 73 citedOpen Access
Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis
New England Journal of Medicine·2025· 88 citedOpen Access
Phase III FIBRONEER-IPF Trial of Nerandomilast in Patients With Idiopathic Pulmonary Fibrosis
American Journal of Respiratory and Critical Care Medicine·2025· 3 cited
Initiation of Supplemental Oxygen in the FIBRONEER-IPF Trial of Nerandomilast in Patients With Idiopathic Pulmonary Fibrosis
American Journal of Respiratory and Critical Care Medicine·2025· 3 cited
Trajectories of forced vital capacity in patients with systemic sclerosis-associated interstitial lung disease
Arthritis Research & Therapy·2025· 3 citedOpen Access
Prognostic prediction for newly diagnosed patients with idiopathic interstitial pneumonia: JIPS Registry (NEJ030)
Respiratory Investigation·2025· 1 citedOpen Access
Baseline characteristics of patients enrolled in FIBRONEER(TM)-IPF, a Phase III randomised placebo-controlled trial of the preferential PDE4B inhibitor BI 1015550 in patients with idiopathic pulmonary fibrosis
Pneumologie·2025
Baseline characteristics of patients enrolled in the FIBRONEER-ILD trial of nerandomilast (BI 1015550)
Pneumologie·2025
Inflammatory and Coagulation Marker Changes in PMX-DHP-Treated COVID-19 Patients
Cureus·2025· 1 citedOpen Access
Pendidikan Kesehatan Pada Remaja Dalam Pencegahan Stunting Di Posyandu Remaja Slukatan
Idea Pengabdian Masyarakat·2025Open Access
Caractéristiques initiales des patients inclus dans FIBRONEER™-IPF, essai de phase III randomisé, contrôlé vs placebo de l’inhibiteur préférentiel PDE4B, nerandomilast, chez des patients atteints d’une FPI
Revue des Maladies Respiratoires Actualités·2025
page 1 of 27Next →

Frequent Co-authors

Shoji Kudoh(17), Yoshikazu Inoue(10), Takashi Ogura(10), Hiroyuki Taniguchi(9), Akihiko Gemma(8), Ganesh Raghu(7), Yukihiko Sugiyama(7), Luca Richeldi(6), Susanne Stowasser(6), Sakae Homma(6), Yoshio Taguchi(6), Yasuhiro Kondoh(6), Jiro Usuki(6), Shinji Abe(6), Vincent Cottin(5), Takeshi Johkoh(5), Toby M. Maher(5), Toshihiro Nukiwa(5), Masahito Ebina(5), Harold R. Collard(4)